Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery: A Randomized, Double-Blinded, Controlled Trial

NCT05871073 is registered in ClinicalTrials.gov with University Hospital Fattouma Bourguiba as lead sponsor.

NCT NCT05871073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05871073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery: A Randomized, Double-Blinded, Controlled Trial
Lead sponsor
University Hospital Fattouma Bourguiba
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2023
Completion date
March 5, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar disc herniation, lumbar spinal stenosis, lumbar spine instability, lumbar spondylolisthesis